142 related articles for article (PubMed ID: 9542692)
1. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
Lewis RW
Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692
[No Abstract] [Full Text] [Related]
2. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
Porst H
Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
[TBL] [Abstract][Full Text] [Related]
3. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Engel JD; McVary KT
Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
[TBL] [Abstract][Full Text] [Related]
4. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences].
Porst H
Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294
[TBL] [Abstract][Full Text] [Related]
5. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
6. [Transurethral alprostadil (MUSE) in erectile dysfunction].
Comeri G; Gianneo E; Nespoli R
Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea.
Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC
Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635
[TBL] [Abstract][Full Text] [Related]
8. Use of transurethral alprostadil (MUSE) (prostaglandin E1) for glans tumescence in a patient with penile prosthesis.
Chew KK; Stuckey BG
Int J Impot Res; 2000 Jun; 12(3):195-6. PubMed ID: 11045915
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection.
Guay AT; Perez JB; Velásquez E; Newton RA; Jacobson JP
Eur Urol; 2000 Dec; 38(6):671-6. PubMed ID: 11111182
[TBL] [Abstract][Full Text] [Related]
10. [Place of intra-urethral prostaglandin E1 for the treatment of erectile dysfunction].
Amar E
Contracept Fertil Sex; 1999; 27(7-8):548-52. PubMed ID: 10495573
[TBL] [Abstract][Full Text] [Related]
11. Titration study of MUSE (Medicated Urethral System for Erection) in erectile dysfunction.
Chiang HS; Wen TC; Liang JF
J Formos Med Assoc; 2000 Dec; 99(12):926-30. PubMed ID: 11155746
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of transurethral application of alprostadil for erectile dysfunction in Indonesians.
Pangkahila WI
Asian J Androl; 2000 Sep; 2(3):233-6. PubMed ID: 11225984
[TBL] [Abstract][Full Text] [Related]
13. Thalassaemic men affected by erectile dysfunction treated with transurethral alprostadil: case report.
Lombardo T; Giammusso B; Frontini V; D'Arpa S; Pafumi C; Caruso S
Hum Reprod; 2000 Nov; 15(11):2375-8. PubMed ID: 11056136
[TBL] [Abstract][Full Text] [Related]
14. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.
Padma-Nathan H; Hellstrom WJ; Kaiser FE; Labasky RF; Lue TF; Nolten WE; Norwood PC; Peterson CA; Shabsigh R; Tam PY; Place VA; Gesundheit N
N Engl J Med; 1997 Jan; 336(1):1-7. PubMed ID: 8970933
[TBL] [Abstract][Full Text] [Related]
15. Transurethral alprostadil for the treatment of erectile dysfunction: results of a multicentre trial.
Li MK; Lim PH; Wong MY; Fok A; Chia SJ; Consigliere D; Adaikan PG; Moorthy P
Ann Acad Med Singap; 2000 Nov; 29(6):727-31. PubMed ID: 11269978
[TBL] [Abstract][Full Text] [Related]
16. Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.
Shabsigh R; Padma-Nathan H; Gittleman M; McMurray J; Kaufman J; Goldstein I
Urology; 2000 Jan; 55(1):109-13. PubMed ID: 10654905
[TBL] [Abstract][Full Text] [Related]
17. MUSE therapy: preliminary clinical observations.
Werthman P; Rajfer J
Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
[TBL] [Abstract][Full Text] [Related]
18. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
Raina R; Pahlajani G; Agarwal A; Zippe CD
BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy.
Costabile RA; Spevak M; Fishman IJ; Govier FE; Hellstrom WJ; Shabsigh R; Nemo KJ; Rapport JL; Tam PY; Weldon KL; Gesundheit N
J Urol; 1998 Oct; 160(4):1325-8. PubMed ID: 9751346
[TBL] [Abstract][Full Text] [Related]
20. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury.
Bodner DR; Haas CA; Krueger B; Seftel AD
Urology; 1999 Jan; 53(1):199-202. PubMed ID: 9886612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
